Bryant. E. Fong
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bryant. E. Fong
Bryant. E. Fong was last confirmed as Chairman at Adma Biologics, Inc. (ADMA) in a filing dated April 15, 2024. Earlier roles on record: Board Member at Adma Biologics, Inc. (ADMA) until November 19, 2024. Adma Biologics, Inc. reported in an 8-K filed November 21, 2024 that Bryant. E. Fong resigned as member of the Company's Board of Directors, effective November 19, 2024.
“On November 19, 2024, Bryant E. Fong notified ADMA Biologics, Inc. (the "Company") that he resigned, effective immediately, as a member of the Company's Board of Directors (the "Board") and any committees of the Board in order to devote more time to his roles as Managing Director of Biomark Capital Fund and as Partner and Co-Portfolio Manager of Stonepine Capital Management.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-04-15
Last confirmed by a filing; no departure on record
-
Start not stated–2024-11-19
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.